FLUBLOK TRIVALENT NORTHERN HEMISPHERE
- Product NDC
- 49281-726
- 11-digit product format
- 492810726
- Labeler code
- 49281
- Product ID
- 49281-726_92606719-3e37-477b-baf9-453cb34f3f50
- Type
- VACCINE
- Nonproprietary name
- INFLUENZA A VIRUS A/Missouri/11/2025 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/Darwin/1415/2025 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/Pennsylvania/14/2025 RECOMBINANT HEMAGGLUTININ ANTIGEN
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR
- Application
- BLA125285
- Marketing category
- BLA
- Marketing start
- 2026-07-02
- Marketing end
- 2027-06-30
- Substance
- INFLUENZA A VIRUS A/MISSOURI/11/2025 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA A VIRUS A/DARWIN/1415/2025 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/PENNSYLVANIA/14/2025 RECOMBINANT HEMAGGLUTININ ANTIGEN
- Active strength
- 45 ug/.5mL
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- FLUBLOK TRIVALENT NORTHERN HEMISPHERE
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| INFLUENZA A VIRUS A/MISSOURI/11/2025 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN | 45 ug/.5mL |
| INFLUENZA A VIRUS A/DARWIN/1415/2025 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN | 45 ug/.5mL |
| INFLUENZA B VIRUS B/PENNSYLVANIA/14/2025 RECOMBINANT HEMAGGLUTININ ANTIGEN | 45 ug/.5mL |
DailyMed Product Concepts#
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 125285 | Flublok | Influenza Vaccine | 351(a) | Rx | 2026-06-01 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Status |
|---|
| 49281-726-10 | 49281072610 | 10 SYRINGE in 1 CARTON (49281-726-10) / .5 mL in 1 SYRINGE (49281-726-88) | 10 syringe | 2026-07-02 | 2027-06-30 | 0 | Historical |